Dorsal Root Ganglion (DRG) Stimulation for Chronic Pain: An Evidence-Based Overview

Neuromodulation is an evolving part of pain medicine that uses small electrical currents to change how the nervous system processes pain. Dorsal root ganglion (DRG) stimulation is one of these treatments. It targets small clusters of nerve cells just outside the spinal cord and is mainly used for long-lasting, difficult-to-treat nerve pain in a specific area of the body. This article explains what DRG stimulation is, how it works, who it may help, and what current research shows.

1. What Is the Dorsal Root Ganglion?

The dorsal root ganglion (DRG) is a small bundle of nerve cell bodies that sits just outside the spinal cord in the opening of each spinal bone. You have many DRGs running down both sides of your spine, usually one for each spinal level and side of the body. Each DRG gathers sensory signals (including pain, temperature, and touch) from a particular region of the body and passes those signals into the spinal cord and then the brain.

Because each DRG serves a fairly specific “map” of the skin and deeper tissues, it acts as a key relay station for pain from that region. Research in both animals and humans shows that nerve cells in the DRG can become overactive or “sensitized” after nerve injury, surgery, or complex regional pain syndrome (CRPS). This ongoing abnormal activity can keep pain signals firing even after tissues have healed.

Targeting the DRG with electrical stimulation allows doctors to influence these pain signals very close to their source, often more precisely than stimulating the main spinal cord itself.

2. How Does DRG Stimulation Work?

DRG stimulation involves placing thin, flexible electrical leads near one or more DRGs and connecting them to a small battery (implantable pulse generator) under the skin. The device sends carefully programmed pulses to the DRG to change how pain signals are transmitted.

The exact ways DRG stimulation reduces pain are still being studied, but current evidence suggests several mechanisms:

Modulating overactive nerve cells: Stimulation can reduce abnormal firing of pain-sensing neurons in the DRG and surrounding nerve fibers.
Changing signal traffic: It may shift the balance between pain and non-pain signals entering the spinal cord, so the brain receives fewer distressing signals from the painful area.
Influencing inflammation and gene activity: Laboratory studies suggest DRG stimulation can alter inflammatory signaling and gene expression involved in chronic pain, although this is still an active area of research.

DRG stimulation is related to, but different from, traditional spinal cord stimulation (SCS):

Focal versus broad coverage: SCS usually stimulates a wider area of the spinal cord, which can help with more diffuse pain (such as both legs). DRG stimulation is more focused. Because each DRG corresponds to a defined body region, DRG stimulation can provide very targeted coverage for a small or tricky-to-reach pain area (for example, the foot, ankle, knee, groin, or part of the pelvis).
More stable lead position: The DRG sits in a bony opening, and the leads are anchored in a relatively confined space. This can reduce lead movement with posture changes compared with some SCS systems, helping maintain more consistent pain relief.
Lower energy needs: Because the target is so close to the nerves being influenced, DRG systems can often run at lower energy levels than some SCS systems. This may prolong battery life and allow smaller pulse generators.
Paresthesia-free options: Traditional SCS often produces a tingling (paresthesia) sensation in the painful area, which some people dislike. DRG systems can be programmed either with paresthesias or at “sub-perception” levels where you feel nothing but can still get pain relief.

3. What Conditions Is DRG Stimulation Used For?

Regulatory approvals vary by country, but based on clinical trials, case series, and practice guidelines, DRG stimulation is most commonly used for:

Complex regional pain syndrome (CRPS) type I and II: Especially when pain is confined to a limb (foot, ankle, knee, hand). The ACCURATE randomized trial and later studies show DRG stimulation can provide meaningful and durable pain relief for many people with CRPS who have not responded to other treatments.
Focal neuropathic pain: Such as pain after nerve injury to a specific nerve branch or dermatome (for example, post-traumatic or post-surgical nerve pain in the leg or trunk).
Post-surgical pain: Persistent pain after surgery such as knee or ankle surgery, hernia repair, hip replacement, or thoracotomy, when pain remains localized and neuropathic in character (burning, electric, shooting).
Groin and pelvic pain: Pain in the groin, lower abdomen, or parts of the pelvis that follow specific nerve distributions (for example, ilioinguinal, genitofemoral, or pudendal-related patterns).
Phantom limb pain: Pain felt in an amputated limb, where DRG stimulation at the spinal level corresponding to the missing limb can sometimes reduce phantom sensations.

Other areas under active research include chronic low back pain with a focal pattern, post-herpetic neuralgia, and certain forms of cancer-related pain. Evidence in these areas is more limited and often comes from small studies or case reports.

4. Am I a Candidate for DRG Stimulation?

DRG stimulation is usually considered only after simpler treatments have been tried and have not provided enough relief. Common features of suitable candidates include:

Chronic, focal neuropathic pain: Pain lasting at least several months (often > 6–12 months), mainly in a specific region that matches one or more DRGs.
Neuropathic pain features: Burning, shooting, electric, or stabbing pain, often with sensitivity to light touch or temperature; sometimes associated with CRPS changes such as color, temperature, or sweating differences.
Incomplete relief from other therapies: You have usually tried and not had adequate benefit from medicines (such as neuropathic pain drugs), physiotherapy, psychological approaches, nerve blocks, and sometimes surgery where appropriate.
Realistic expectations: The goal is meaningful pain reduction and improved function, not a guaranteed cure. Many programs look for patients aiming for better activity, sleep, and quality of life rather than complete pain elimination.
Ability to manage an implanted device: You (or a caregiver) need to be able to use a handheld programmer, attend follow-up visits, and report changes in symptoms.

Psychological screening is commonly part of the assessment. This is not about judging your pain as “real” or “unreal” but about understanding mood, coping, expectations, and any factors (such as severe untreated depression, substance use disorder, or significant anxiety) that might affect your outcome. Evidence suggests that people with severe psychological distress or unrealistic expectations may be less likely to benefit from neuromodulation.

People who are usually not suitable for DRG stimulation include:

Those with untreated serious mental health conditions, active psychosis, or active substance use disorder.
People with widespread pain (such as fibromyalgia or generalized pain) where there is no clear focal area to target.
Individuals with uncontrolled bleeding disorders or on blood thinners that cannot be safely paused for the procedure.
People with active infection or serious medical instability that makes surgery too risky.
Those who are unable to understand the procedure, provide informed consent, or manage the device.

Final decisions about suitability are made by a multidisciplinary pain or neuromodulation team, based on clinical examination, imaging, and overall health status.

5. How Is the DRG Stimulation Procedure Done?

DRG stimulation is typically done in two stages: a temporary trial and, if successful, a permanent implant. Steps may vary between centers, but the general process is similar.

Stage 1: Trial Period

Preparation: You will usually have pre-operative assessments, including review of medications (especially blood thinners), imaging of your spine, and sometimes blood tests. You will be advised when to stop eating and drinking before the procedure.
Anaesthesia: The trial is often done under local anaesthetic with light sedation, or occasionally under general anaesthetic, depending on your health and the center’s practice.
Lead placement: Under X-ray (fluoroscopy) guidance, the doctor inserts thin leads through a needle into the space around the spinal nerves, then carefully positions each lead near the target DRG. You may be asked about where you feel sensations during this process if paresthesia-based programming is used.
Connection to external pulse generator: The leads are taped to your skin and connected to an external battery and programmer worn on a belt or in a pocket.
Trial duration and assessment: The trial usually lasts around 5–7 days. During this time, you go home and keep a pain and activity diary. The team will adjust settings to optimize relief.

A trial is usually considered successful if you achieve around 50% or greater reduction in pain and/or a clear improvement in function, sleep, or daily activities. Some programs also look for reduced pain medicines or clear improvements in specific goals important to you.

Stage 2: Permanent Implant

Implant decision: If the trial is successful and you wish to proceed, you return for a second procedure.
Anaesthesia: The permanent implant is usually done under general anaesthetic or deeper sedation.
Lead placement and anchoring: Leads are re-inserted or adjusted to the same target DRGs and then firmly anchored to reduce movement.
Implanting the pulse generator: A small pocket is created under the skin (commonly in the upper buttock, flank, or abdomen), and the implantable pulse generator (battery) is placed and connected to the leads.
Imaging guidance and testing: X-ray is used to confirm lead location. The system is tested during surgery to check connections and basic function.
Recovery: You typically go home the same day or after an overnight stay. There may be activity restrictions (such as avoiding heavy lifting, twisting, or bending) for several weeks to allow tissues to heal and minimize lead movement.

Follow-up visits are used to adjust settings, check wound healing, and gradually help you return to normal or increased activities.

6. What Does DRG Stimulation Feel Like?

What you feel depends on how your device is programmed:

Paresthesia-based stimulation: You feel a tingling, buzzing, or gentle vibration in the painful area when the device is on. Ideally, this sensation overlaps with your area of pain without being uncomfortable or distracting.
Sub-perception (paresthesia-free) stimulation: The device runs at levels or patterns where you do not feel the stimulation at all, yet may still get pain relief. Many modern DRG systems offer these modes.

After the implant, you will attend one or more programming sessions. A specialist uses a wireless programmer to adjust which contacts on the leads are active, the strength and pattern of stimulation, and whether paresthesia is used. You typically receive a handheld controller to switch programs, turn the device on or off, and sometimes adjust the intensity within a safe range.

Your sensations can change over time as your nervous system adapts, your pain pattern evolves, or you change activities. Regular follow-up is important so your team can fine-tune settings to maintain the best balance of pain relief and comfort.

7. What Does the Evidence Say?

Compared with many other chronic pain treatments, DRG stimulation has a growing but still relatively limited evidence base. Key sources include randomized controlled trials, prospective cohort studies, and systematic reviews.

The ACCURATE Trial (CRPS and Causalgia)

The ACCURATE trial was a multicenter randomized controlled study comparing DRG stimulation with traditional spinal cord stimulation in people with CRPS or causalgia (nerve injury pain) of the lower limbs. Participants had chronic, focal neuropathic pain that had not improved with other therapies.

Key findings at 12 months included:

Responder rate (at least 50% pain relief): About 74.2% of people in the DRG group were responders, compared with about 53% in the SCS group.
Superiority over SCS: DRG stimulation met predefined criteria for being superior to SCS in this population.
Other outcomes: People with DRG stimulation also showed improvements in quality of life, mood, and some measures of function, and reported less variation in pain relief with changes in body position.

These results support DRG stimulation as an effective option for CRPS and focal nerve injury pain in the lower limbs, especially when other treatments have failed.

Systematic Reviews, Cochrane, and Recent Updates

Systematic reviews, including Cochrane reviews that examine both spinal cord and DRG stimulation, generally conclude that neuromodulation can provide meaningful pain relief for some people with chronic neuropathic pain, particularly CRPS and failed back surgery syndrome. For DRG specifically, the evidence suggests moderate to high rates of pain relief and improved quality of life in selected patients, especially for focal pain conditions.

However, these reviews also highlight important limitations:

Many DRG studies are relatively small or observational.
Follow-up is often limited to one or two years, so very long-term outcomes (beyond 5–10 years) are less clear.
Most data are in CRPS and lower-limb neuropathic pain; evidence for other indications (such as pelvic pain or phantom limb pain) is promising but still low to moderate in quality.

Recent publications up to 2024 report that a substantial proportion of people maintain significant pain relief and functional improvement for several years, but not everyone benefits, and some lose benefit over time or need revisions. Overall, expert guidelines tend to support DRG stimulation for carefully selected patients with focal neuropathic pain, particularly CRPS, while emphasizing the need for ongoing high-quality research and longer-term follow-up.

No procedure can guarantee success, and the published numbers are averages. Your own outcome may be better or worse than the group results, which is why a temporary trial is so important before committing to a permanent implant.

8. Risks and Side Effects

Like any invasive procedure, DRG stimulation carries risks. Some are similar to spinal cord stimulation, while others differ because of the unique anatomy of the DRG and the way leads are placed.

Lead migration or movement: The leads can shift from their original position. In DRG systems, lead-related issues have been reported fairly often in some series. Movement can reduce pain relief or change where you feel stimulation and may sometimes require another procedure to reposition or replace the leads.
Infection: As with any implanted device, there is a risk of infection at the incision sites or around the hardware. Mild infections may respond to antibiotics; more serious infections may require device removal.
Hardware problems: Leads can break, disconnect, or malfunction. The pulse generator can also fail or reach the end of its battery life. These issues may require surgical revision or replacement.
Overstimulation or unwanted sensations: Tingling, buzzing, or jolts can be uncomfortable if settings are too strong or if leads move. Reprogramming usually helps; occasionally, hardware adjustment is needed.
Nerve or spinal complications (rare): There is a small risk of nerve injury, bleeding around the spinal cord or nerves (epidural hematoma), or spinal fluid leak. These events are uncommon but can be serious and may need urgent treatment.
General surgical risks: Pain at the implant site, bruising, scarring, and anaesthetic risks, especially in people with other medical conditions.

Your team should discuss these risks in detail, including how often they occur in their own practice and what would be done if complications arise. It is reasonable to ask how many DRG procedures your center performs and what their revision and infection rates are.

9. Practical Considerations in Daily Life

MRI and imaging: MRI compatibility depends on the specific device model and the part of the body being scanned. Many newer systems are “MRI-conditional,” meaning MRI is possible under strict conditions. You must always tell imaging staff that you have an implanted device and carry your device identification card.
Driving: Policies vary, but some clinicians recommend turning stimulation off while driving, especially if it can cause sudden changes in sensation. Local driving regulations and your doctor’s advice should be followed.
Battery life: Some devices have non-rechargeable batteries that last several years and then need replacement surgery. Others are rechargeable and can last longer if regularly charged. How you use the device (intensity and hours per day) also affects battery life.
Remote programming: Some systems allow remote or telehealth-based programming adjustments, which can reduce the need for in-person visits. Ask your team what options are available.
Work and activity: After healing, many people can return to work and daily activities, including gentle exercise. Contact sports or heavy lifting may be discouraged, particularly activities that involve extreme bending or twisting of the spine, which might affect lead stability. Your team will give specific guidance for your situation and job.
Airport security and medical devices: Implantable stimulators can trigger metal detectors. Carry your device card and inform security staff. The device is designed to withstand typical security scanners, but prolonged direct wanding over the device is often discouraged.

10. Key Points

DRG stimulation is a form of neuromodulation that targets small nerve clusters near the spinal cord to treat chronic, focal neuropathic pain.
It is most often used for conditions like CRPS, post-surgical nerve pain, and localized neuropathic pain that have not responded to other treatments.
The ACCURATE trial and other studies show that DRG stimulation can provide substantial pain relief for many people, sometimes outperforming traditional spinal cord stimulation in CRPS and causalgia.
A temporary trial is done first; a permanent implant is considered only if you experience meaningful pain and function improvement.
Risks include lead movement, infection, and hardware issues, as well as rare but serious nerve or spinal complications.
Evidence is promising but not perfect; long-term outcomes and results for some indications are still being studied, so decisions should be made in partnership with an experienced pain or neuromodulation team.

11. Questions to Ask Your Doctor

Do you think my type of pain is suitable for DRG stimulation, and why?
What other treatment options are still available to me, and how does DRG stimulation compare with them?
How many DRG stimulation procedures has your team performed, and what are your typical success, infection, and revision rates?
What will the trial involve for me day-to-day, and how will we decide whether it is successful?
What specific risks apply in my case, given my other medical conditions and medications?
How might an implant affect my work, driving, exercise, and future medical tests such as MRI?

12. Disclaimer

This article is for general information and education only. It does not provide medical advice, diagnosis, or treatment, and it is not a substitute for seeing your own licensed healthcare professional. Always speak with your doctor or another qualified health provider about your specific symptoms, questions, or before making decisions about your care.